Supernus Pharmaceuticals, Inc. (SUPN)
47.16
+0.65
(+1.40%)
USD |
NASDAQ |
Dec 12, 16:00
47.18
+0.02
(+0.04%)
Pre-Market: 20:00
Supernus Pharmaceuticals EPS Diluted (TTM): -0.3408 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biogen, Inc. | 10.97 |
| BridgeBio Pharma, Inc. | -4.187 |
| CorMedix, Inc. | 2.053 |
| Assembly Biosciences, Inc. | -4.802 |
| Viking Therapeutics, Inc. | -2.118 |